or Try an Advanced Search...

    Digestive Diseases Stocks List

    Symbol Grade Name % Change
    MIRM B Mirum Pharmaceuticals, Inc. 5.04
    LUCD C Lucid Diagnostics Inc. -5.01
    BIVI D BioVie Inc. 1.09
    MCRB F Seres Therapeutics, Inc. 0.26
    IRWD F Ironwood Pharmaceuticals, Inc. 6.08
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Gastroenterology Hepatology Liver Medicine Acid Antibiotics Antimicrobial Resistance Autoimmune Disease Bile Acid Cancer Cardiovascular Disease Cdi Central Nervous System Disorders Cholestasis Chronic Idiopathic Constipation Clinical Development Clinical Medicine Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection

    Related ETFs - A few ETFs which own one or more of the above listed Digestive Diseases stocks.

    Symbol Grade Name Weight
    ACTV D LeaderShares Activist Leaders ETF 3.19
    BBP A BioShares Biotechnology Products Fund 3.18
    HRTS D Tema Cardiovascular and Metabolic ETF 2.08
    SBIO B ALPS Medical Breakthroughs ETF 1.65
    DEEP D Roundhill Acquirers Deep Value ETF 0.91
    View all Digestive Diseases ETFs...
    Compare ETFs
    Compare ACTV to BBP Compare ACTV to SBIO Compare BBP to SBIO

        Digestive Diseases Stocks Recent News

        Date Stock Title
        Oct 31 BIVI (BIVI) - Analyzing BioVie's Short Interest
        Oct 31 MIRM Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
        Oct 31 LUCD PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
        Oct 31 MIRM Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
        Oct 30 LUCD Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
        Oct 29 BIVI BioVie Inc. Announces Closing of Registered Direct Offering
        Oct 28 BIVI UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
        Oct 28 BIVI BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
        Oct 28 IRWD Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Gastroenterology Hepatology Liver Medicine Acid Antibiotics Antimicrobial Resistance Autoimmune Disease Bile Acid Cancer Cardiovascular Disease Cdi Central Nervous System Disorders Cholestasis Chronic Idiopathic Constipation Clinical Development Clinical Medicine Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection
        Digestive Diseases

        Karger Publishers (also: Karger Medical and Scientific Publishers, S. Karger AG) is an academic publisher of scientific and medical journals and books. The current CEO is Gabriella Karger.

        More about Digestive Diseases
        Browse All Tags